Medvi, glorified by the NYT as a two-employee startup with $1B+ in revenue, is a warning for how AI can be abused for scammy business and marketing practices
AI isn't the only thing behind Medvi — On Thursday, The New York Times published a thing — and it went viral, declared as a victory for AI:
Marcus on AI Gary Marcus
Related Coverage
- HomePod Mini Is Now 2,000 Days Old MacRumors · Hartley Charlton
- Telehealth startup Medvi generated billions in revenue with AI-powered fake advertising The Decoder · Matthias Bastian
- billion dollar ai company was built on lies voidzilla on YouTube · Voidzilla
- Reposting this from Gary Marcus because it touches a pattern that is becoming far too familiar in the AI conversation. … Margaritis
- Kind of sad that the first “$1b solo” business is a complete pile of scam and fraud - https://lnkd.in/... It sounded fishy to me from the get, and Gary Marcus confirms it. … Matt Pogue
- 😸 AI did WHAT for $20K? … It can make mistakes, and it may not work as intended. TheNeuron · Eric Gerard Ruiz
- Medvi the latest AI meditech cum brand story of a telehealth company selling weight-loss drugs, got a great paid for plug in the NYT. … Neil Gentleman-Hobbs
- Why Is the New York Times Laundering the Reputation of a Sleazy AI Startup That's Selling GLP-1s via a Dishonest Dumpster Fire of Fake Doctors … Futurism · Maggie Harrison Dupré
- Medvi Got an FDA Warning Before the Times Called It a $1.8 Billion AI Story Implicator.ai · Maria Garcia
- The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed ‘fastest growing company in history.’ Drug Discovery and Development · Brian Buntz
- Lessons From the First Billion Dollar 1-Person Company TBPN · Brandon Gorrell
Discussion
-
@brand
@brand
on x
BREAKING 🚨: This is extremely illegal. This is Matthew Gallagher, who created 800+ Facebook accounts posing as fake doctors to advertise on Facebook, and went on to build a GLP-1 telehealth company with just $20,000, AI, and only one full-time teammate, his brother. The New York …
-
@aakashgupta
Aakash Gupta
on x
The NYT just profiled Medvi as the AI success story of the decade. $1.8B in projected revenue, 2 employees, Sam Altman's prediction made real. Here's what the NYT didn't lead with. Medvi received FDA Warning Letter #721455 in February 2026 for misbranding violations. Their
-
@rwmalonemd
Robert W Malone
on x
NYT screwed the pooch yet again.
-
@pitdesi
Sheel Mohnot
on x
they have ~800 ads running right now from fake doctors (and another 4,000 running with fake testimonials and from fake organizations). This is highly illegal (using an AI generated doctor image and quote). The same quote is being used by hundreds of doctors (who are not real) [im…
-
@robertfreundlaw
Rob Freund
on x
Interesting telehealth class action lawsuit: A guy bought “oral tirzepatide” from MEDvi (not a defendant). Problem is, allegedly, oral tirzepatide is not a compound that actually exists. It is allegedly impossible for it to exist. Inert. He's suing OpenLoop and Triad for [image]
-
@garymarcus
Gary Marcus
on x
I am appalled by the puff piece NYT wrote about “billion dollar” company Medvi. Here's a very different perspective: https://garymarcus.substack.com/ ...
-
@pitdesi
Sheel Mohnot
on x
They made facebook accounts for 800+ fake doctors (I had Claude verify, none of them are actually doctors, especially not “Dr. Tuckr Carlzyn MD") to advertise on Facebook. This is extremely illegal, just takes FTC to notice it and it'll be hard for them to advertise on FB [image]
-
@adi_baradwaj
Adi
on x
So... have we just accepted that fraud is how Silicon Valley operates now? Medvi, Delve, Mercor, Cluely - and that's just in the past couple weeks
-
@finn3v
Finn
on x
The entire Medvi run is a case study of just absolute big dicking it at every turn, in the most eggregious way possible, with 0 fucks given in any way Men can't conquer the world anymore so they run up $1b blackhat schemes and then flex on new york times Lesson in there
-
@rhyssullivan
Rhys
on x
Great video by @coffeebreak_YT breaking down questionable aspects of Medvi - Has an FDA warning letter - Ads w/ fake doctors - AI generated before / after photos & testimonials NYT article mentions none of this for some reason, full video in reply [video]
-
@ssaaammiirr
@ssaaammiirr
on x
Hot take: the Medvi story has nothing to do with AI. A guy built a $1.8B company with 2 people. Cool. But strip away the AI headline and look at what's underneath: Telehealth subscriptions. I've been in this space. I've seen the numbers up close. The LTVs are borderline unfair
-
@kekius_sage
Kekius Maximus
on x
Medvi received FDA Warning Letter #721455 in February 2026 for misbranding violations. Their clinician network OpenLoop suffered a data breach in January 2026 that exposed 1.6 million patient records. Futurism reported they used AI-generated deepfake before-and-after photos in [i…
-
@choffstein
@choffstein
on x
somewhere along the way, “move fast and break things” turned into “move fast and break laws” [image]
-
@zachweinberg
@zachweinberg
on x
The @nytimes writes a hype piece about a clear healthcare scam and at no point goes “hey maybe something is off here?” And people wonder why no one in the business world trusts NYT to be objective? You guys barely understand how anything works! It's embarrassing incompetence.
-
@antinertia
Jeddi
on x
medvi is only the tip of the iceberg if you knew how people are scaling with ai ugc fake doctors are nothing compared to what really happens in the ai ugc industry oh god you are so naive
-
@anothercohen
Alex Cohen
on x
Friend got a marketing email from Medvi this morning. Email copy aside, the provider they are using in the screenshot is an actual doctor, not an NP, whose real name is Alec Wier, and he is COMPLETELY UNAFFILIATED with Medvi. This entire company is run on fraud and deception [ima…
-
@galligator
Matthew Gallagher
on x
Watching in realtime as people learn about white label, drop shipping, and affiliate marketing is like seeing cavemen “fire bad” White label telemedicine is a huge benefit with a net positive for humanity. It has been the driving force behind big pharma lowering prices and
-
@robertfreundlaw
Rob Freund
on x
Medvi was sued in a class action last month for violating California's anti-spam law. “MEDVi's affiliate marketers send spam use falsified header information, spoofed domains and nonsensical sending addresses to evade spam filters. They also use false and deceptive subject [image…
-
@robertfreundlaw
Rob Freund
on x
One hundred percent correct. If you're building a brick-and-mortar local bakery, ok. If you're building a “selling fake drugs that don't exist promoted by fake doctors who don't exist” business, definitely stfu!
-
@coyington
Garland-Coy
on x
I think this Medvi situation is the perfect reason why you do not follow the absolute brain dead take “build in public” Even ignoring the actual issues, when you're big enough, everyone is going to come for you.
-
@slotkinjr
Dr. Jon Slotkin
on x
I really did not want to be writing this morning. But this issue is too important. It's been said that the last thing the weather person should do before going on the air is look out the window. The _day before_ @eringriffith profiled Medvi in @nytimes as the AI company of the
-
@mags_h11
Maggie Harrison Dupré
on x
In May 2025, I first reported that Medvi was very obviously fabricating before-and-after weight loss images of purported GLP-1 customers who were not real. “Sometimes you have to see it to believe it,” the company stated next to the falsified images. https://futurism.com/... [ima…
-
@alexgroberman
Alex Groberman
on x
Confused as to why Matthew Gallagher and Medvi are catching so much heat. Still haven't seen one person calling them scammers explain why. The New York Times verified the financials. Hims and Hers is a publicly traded telehealth company prescribing the same category of weight
-
@druce.ai
@druce.ai
on bluesky
Is Medvi an AI-powered fraud machine?